Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENETOCLAX vs VENLAFAXINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VENETOCLAX vs VENLAFAXINE: Safety Overview

Metric VENETOCLAX VENLAFAXINE
Total FAERS Reports 53,724 47,931
Deaths Reported 15,763 7,521
Death Rate 29.3% 15.7%
Hospitalizations 20,812 15,749
Average Patient Age 67.9 yrs 49.5 yrs
% Female Patients 37.6% 68.7%
FDA Approval Date Apr 11, 2016 Apr 12, 2023
Manufacturer AbbVie Inc. Bryant Ranch Prepack
Route ORAL ORAL
Marketing Status Prescription Discontinued